Aarey Drugs & Pharmaceuticals (NSE:AAREYDRUGS) Days Sales Outstanding : 130.69 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Aarey Drugs & Pharmaceuticals Days Sales Outstanding?

Aarey Drugs & Pharmaceuticals's average Accounts Receivable for the three months ended in Dec. 2023 was ₹1,095 Mil. Aarey Drugs & Pharmaceuticals's Revenue for the three months ended in Dec. 2023 was ₹765 Mil. Hence, Aarey Drugs & Pharmaceuticals's Days Sales Outstanding for the three months ended in Dec. 2023 was 130.69.

The historical rank and industry rank for Aarey Drugs & Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

NSE:AAREYDRUGS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 71.13 Med: 111.62 Max: 153.7
Current: 153.7

During the past 13 years, Aarey Drugs & Pharmaceuticals's highest Days Sales Outstanding was 153.70. The lowest was 71.13. And the median was 111.62.

NSE:AAREYDRUGS's Days Sales Outstanding is ranked worse than
90.58% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.84 vs NSE:AAREYDRUGS: 153.70

Aarey Drugs & Pharmaceuticals's Days Sales Outstanding declined from Dec. 2022 (193.95) to Dec. 2023 (130.69).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Aarey Drugs & Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Aarey Drugs & Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarey Drugs & Pharmaceuticals Days Sales Outstanding Chart

Aarey Drugs & Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

103.44

122.77

135.42

110.74

144.14

Aarey Drugs & Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															193.95	110.46	339.85	172.83	130.69

Competitive Comparison of Aarey Drugs & Pharmaceuticals's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Aarey Drugs & Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aarey Drugs & Pharmaceuticals's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aarey Drugs & Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Aarey Drugs & Pharmaceuticals's Days Sales Outstanding falls into.

Aarey Drugs & Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Aarey Drugs & Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (1362.83	+	1897.797)	/	2 )	/	4128.498	*	365
=	1630.3135					/	4128.498	*	365
=	144.14

Aarey Drugs & Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1095.351	+	0)	/	1 )	/	764.765	*	365 / 4
=	1095.351					/	764.765	*	365 / 4
=	130.69

Aarey Drugs & Pharmaceuticals (NSE:AAREYDRUGS) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Aarey Drugs & Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Aarey Drugs & Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Aarey Drugs & Pharmaceuticals (NSE:AAREYDRUGS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarey Drugs & Pharmaceuticals Ltd (NSE:AAREYDRUGS) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

524412:India

Address

340/348, Narshi Natha Street, 107, Sahakar Bhavan, Masjid, Mumbai, MH, IND, 400 009

Website

http://www.aareydrugs.com

Aarey Drugs & Pharmaceuticals Ltd is engaged in bulk drug manufacturing and offers products for industrial applications. The company manufactures active pharmaceutical ingredients, intermediates, and specialty chemicals. It is also involved in the trading of industrial solvents and chemicals. The products offered by the company include N-Methyl urea, Dimethyl urea, Mefenamic acid, Metformin, Doxaphylline, BMD among others. The company principally carries its business operations in India.

Aarey Drugs & Pharmaceuticals (NSE:AAREYDRUGS) Headlines

No Headlines